The evolving landscape of sex-based differences in lung cancer: a distinct disease in women

Meera Ragavan, Manali I. Patel

Source: Eur Respir Rev, 31 (163) 210100; 10.1183/16000617.0100-2021
Journal Issue: March

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Meera Ragavan, Manali I. Patel. The evolving landscape of sex-based differences in lung cancer: a distinct disease in women. Eur Respir Rev, 31 (163) 210100; 10.1183/16000617.0100-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers of lung cancer in a general population sample: distribution and relationship with risk factors for respiratory disorders
Source: Eur Respir J 2003; 22: Suppl. 45, 485s
Year: 2003

The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006

Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC)
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019


Challenges in molecular testing in lung cancer patients with advanced disease
Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management
Year: 2016


Association between young age and genomic alterations in never-smoker patients with non–small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020

The terms of adaptation of functional systems of patients with lung cancer and secondary inflammatory changes after surgical treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 750s
Year: 2006

The relationship of pain, uncertainty, and hope in Taiwanese lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 439s
Year: 2003

What is the evidence that ethnic differences in the prevalence of respiratory disease are explained by differences in genetic make-up?
Source: International Congress 2015 – Respiratory disease in minority groups
Year: 2015



COPD: different psychology changes in the patients with different severity of disease
Source: Annual Congress 2007 - Clinical aspects of COPD II
Year: 2007


Family and personal history of cancer: how common and how clinically significant is in lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 361s
Year: 2003

What is real prevalence of COPD in patients with lung cancer?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


Women lung cancer: factors related to survival
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006

Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features
Source: Eur Respir J 2006; 28: Suppl. 50, 335s
Year: 2006

An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010


The Asian experience in co-existing lung cancer and interstitial lung disease
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018


BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers
Source: Eur Respir J 2015; 45: 1403-1414
Year: 2015